Informações:
Falhas:
ID
19648
Descrição
Studying Biomarkers in Nipple Fluid, Urine, and Blood Samples From Women With Newly Diagnosed Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer and in Women at Risk of Developing Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00897208
Link
https://clinicaltrials.gov/show/NCT00897208
Palavras-chave
Versões (1)
- 18/01/2017 18/01/2017 -
Transferido a
18 de janeiro de 2017
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Breast Cancer NCT00897208
Eligibility Breast Cancer NCT00897208
- StudyEvent: Eligibility
Similar models
Eligibility Breast Cancer NCT00897208
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
criteria Fulfill
Item
meets 1 of the following criteria:
boolean
C0243161 (UMLS CUI [1,1])
C1550543 (UMLS CUI [1,2])
C1550543 (UMLS CUI [1,2])
Breast Carcinoma TNM clinical staging
Item
newly diagnosed (within 30 calendar days of diagnosis) stage i or ii breast cancer
boolean
C0678222 (UMLS CUI [1,1])
C3258246 (UMLS CUI [1,2])
C3258246 (UMLS CUI [1,2])
Disease Negative Lymph Node | Disease lymph node positive
Item
node-negative or node-positive disease
boolean
C0012634 (UMLS CUI [1,1])
C0678034 (UMLS CUI [1,2])
C0012634 (UMLS CUI [2,1])
C0746319 (UMLS CUI [2,2])
C0678034 (UMLS CUI [1,2])
C0012634 (UMLS CUI [2,1])
C0746319 (UMLS CUI [2,2])
Noninfiltrating Intraductal Carcinoma TNM clinical staging
Item
newly diagnosed ductal carcinoma in situ (stage 0) of the breast
boolean
C0007124 (UMLS CUI [1,1])
C3258246 (UMLS CUI [1,2])
C3258246 (UMLS CUI [1,2])
At high risk for breast cancer
Item
at high risk of developing breast cancer, as indicated by at least 1 of the following criteria:
boolean
C4047809 (UMLS CUI [1])
Risk Percentage Year Quantity Gail Risk Model
Item
gail model 5-year risk score ≥ 1.66%
boolean
C0035647 (UMLS CUI [1,1])
C0439165 (UMLS CUI [1,2])
C0439234 (UMLS CUI [1,3])
C1265611 (UMLS CUI [1,4])
C1511297 (UMLS CUI [1,5])
C0439165 (UMLS CUI [1,2])
C0439234 (UMLS CUI [1,3])
C1265611 (UMLS CUI [1,4])
C1511297 (UMLS CUI [1,5])
Lifetime Risk Percentage Gail Risk Model
Item
gail model lifetime-risk estimate ≥ 20%
boolean
C1517878 (UMLS CUI [1,1])
C0439165 (UMLS CUI [1,2])
C1511297 (UMLS CUI [1,3])
C0439165 (UMLS CUI [1,2])
C1511297 (UMLS CUI [1,3])
BRCA1 Mutation Carrier Deleterious | BRCA2 Mutation Carrier Deleterious
Item
known deleterious brca 1 or 2 gene mutation carrier
boolean
C3899965 (UMLS CUI [1,1])
C2985436 (UMLS CUI [1,2])
C3899964 (UMLS CUI [2,1])
C2985436 (UMLS CUI [2,2])
C2985436 (UMLS CUI [1,2])
C3899964 (UMLS CUI [2,1])
C2985436 (UMLS CUI [2,2])
Non-infiltrating lobular carcinoma | Atypical ductal hyperplasia | Atypical lobular hyperplasia
Item
history of lobular carcinoma in situ or atypical ductal or lobular hyperplasia
boolean
C0334381 (UMLS CUI [1])
C0442834 (UMLS CUI [2])
C0442835 (UMLS CUI [3])
C0442834 (UMLS CUI [2])
C0442835 (UMLS CUI [3])
Breast Carcinoma Low Risk | Breast Carcinoma Risk Average
Item
at low or average risk of developing breast cancer (control group)
boolean
C0678222 (UMLS CUI [1,1])
C3538919 (UMLS CUI [1,2])
C0678222 (UMLS CUI [2,1])
C0035647 (UMLS CUI [2,2])
C1510992 (UMLS CUI [2,3])
C3538919 (UMLS CUI [1,2])
C0678222 (UMLS CUI [2,1])
C0035647 (UMLS CUI [2,2])
C1510992 (UMLS CUI [2,3])
Risk Percentage Year Quantity Gail Risk Model | Lifetime Risk Percentage Gail Risk Model
Item
gail model 5-year risk score < 1.66% or lifetime risk < 20%
boolean
C0035647 (UMLS CUI [1,1])
C0439165 (UMLS CUI [1,2])
C0439234 (UMLS CUI [1,3])
C1265611 (UMLS CUI [1,4])
C1511297 (UMLS CUI [1,5])
C1517878 (UMLS CUI [2,1])
C0439165 (UMLS CUI [2,2])
C1511297 (UMLS CUI [2,3])
C0439165 (UMLS CUI [1,2])
C0439234 (UMLS CUI [1,3])
C1265611 (UMLS CUI [1,4])
C1511297 (UMLS CUI [1,5])
C1517878 (UMLS CUI [2,1])
C0439165 (UMLS CUI [2,2])
C1511297 (UMLS CUI [2,3])
Advanced breast cancer
Item
no advanced breast cancer
boolean
C3495917 (UMLS CUI [1])
Hormone Receptor Status Unspecified
Item
hormone receptor status not specified
boolean
C0019929 (UMLS CUI [1,1])
C0449438 (UMLS CUI [1,2])
C0205370 (UMLS CUI [1,3])
C0449438 (UMLS CUI [1,2])
C0205370 (UMLS CUI [1,3])
Client Characteristics
Item
patient characteristics:
boolean
C0815172 (UMLS CUI [1])
Premenopausal state | Postmenopausal state
Item
pre- or post-menopausal
boolean
C0232969 (UMLS CUI [1])
C0232970 (UMLS CUI [2])
C0232970 (UMLS CUI [2])
Therapeutic procedure
Item
prior concurrent therapy:
boolean
C0087111 (UMLS CUI [1])
Chemotherapy Breast Carcinoma | Chemotherapy Malignant Neoplasms
Item
no prior chemotherapy for breast cancer or any other cancer
boolean
C0392920 (UMLS CUI [1,1])
C0678222 (UMLS CUI [1,2])
C0392920 (UMLS CUI [2,1])
C0006826 (UMLS CUI [2,2])
C0678222 (UMLS CUI [1,2])
C0392920 (UMLS CUI [2,1])
C0006826 (UMLS CUI [2,2])
Estrogen hormone therapy | Hormone Therapy
Item
more than 3 months since prior and no concurrent estrogen or other hormones
boolean
C0474186 (UMLS CUI [1])
C0279025 (UMLS CUI [2])
C0279025 (UMLS CUI [2])
Contraceptives, Oral
Item
more than 3 months since prior oral contraceptives
boolean
C0009905 (UMLS CUI [1])
Selective Estrogen Receptor Modulators | Tamoxifen Citrate | Raloxifene
Item
no concurrent selective estrogen receptor modulators (tamoxifen citrate or raloxifene)
boolean
C0732611 (UMLS CUI [1])
C0079589 (UMLS CUI [2])
C0244404 (UMLS CUI [3])
C0079589 (UMLS CUI [2])
C0244404 (UMLS CUI [3])
Aromatase Inhibitors
Item
no concurrent aromatase inhibitors
boolean
C0593802 (UMLS CUI [1])